Dr. Feyssa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5401 Old York Rd
Ste 505
Philadelphia, PA 19141Phone+1 215-456-8242Fax+1 215-456-8058
Education & Training
- MedStar Health/Harbor HospitalResidency, Internal Medicine, 2003 - 2006
- Jimma University College of Public Health and Medical SciencesClass of 1995
Certifications & Licensure
- NJ State Medical License 2006 - 2025
- PA State Medical License 2007 - 2024
- TX State Medical License 2007 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Obesity Medicine Obesity Medicine
Clinical Trials
- Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients Start of enrollment: 2011 Oct 01
- A Prospective Cohort Study to Improve HCV Care in Dialysis Patients Start of enrollment: 2019 Jan 01
Publications & Presentations
PubMed
- 57 citationsEmricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension.Guadalupe Garcia-Tsao, Michael Fuchs, Mitchell L. Shiffman, Brian B. Borg, Nikolaos Pyrsopoulos
Hepatology. 2019-02-01 - 15 citationsPreoperative elective transjugular intrahepatic portosystemic shunt for cirrhotic patients undergoing abdominal surgery.Deepanshu Jain, Ejaz Mahmood, Maria V-Bandres, Eyob Feyssa
Annals of Gastroenterology. 2018-03-15 - Overcoming a treatment barrier in treating hepatitis C in dialysis patients.Kamolyut Lapumnuaypol, Eyob Feyssa
Seminars in Dialysis. 2018-02-05
Press Mentions
- More People Can Be Treated in Pennsylvania for Nation’s Deadliest Communicable DiseaseJanuary 12th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: